uniQure N.V.

QURE ·Healthcare, Drug Manufacturers - General
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014
Revenue $13.1M $25.1M $10.6M $6.1M
Cost of Revenue $817.0K $1.3M — —
Gross Profit $12.3M $23.8M — —
Gross Margin 93.8% 94.6% — —
Operating Expenses
Research & Development $72.2M $72.5M $59.1M $43.8M
SG&A Expense $24.6M $26.0M $23.4M $17.1M
Operating Income $-71.3M $-71.9M $-71.2M $-53.7M
Operating Margin -544.3% -286.7% -672.6% -874.2%
Interest Expense $2.2M $2.2M $2.6M $2.0M
Pretax Income $-79.5M $-72.2M $-83.3M $-50.3M
Income Tax Expense $-199.0K $1.1M $-1.2M $-535.0K
Net Income $-79.3M $-73.4M $-82.1M $-49.8M
Net Margin -604.7% -292.3% -776.0% -810.6%
EPS (Basic) $-2,940.00 $-2.93 $-3.72 $-2.91
EPS (Diluted) $-2,940.00 $-2.93 $-3.72 $-2.91
Shares Outstanding (Basic) 31.3M 25.3M 24.3M —
Shares Outstanding (Diluted) 31.3M 25.3M 24.3M —
Dividends Per Share — — — —
← Newer Page 2 of 2 Older →